Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous iron on FGF23 and iron profile in hemodialysis patients
IRCT20190506043488N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Iron in iron deficiency anemia (IDA) and end-stage kidney disease (ESKD), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Change in FGF23 levels and Change in iron profile. Started Oct 2019; status: completed.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20190506043488N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043488N1.